Specific, sensitive, and rapid assay for human immunodeficiency virus type 1 pol mutations associated with resistance to zidovudine and didanosine.

The effectiveness of antiretroviral therapy may be limited by the development of human immunodeficiency virus type 1 (HIV-1) resistance. Monitoring for resistance will perhaps allow changes in therapy prior to deterioration in the patient's clinical or immunologic status. Our objective was to develo...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	J Clin Microbiol
Egile Nagusiak:	Frenkel, L M, Wagner, L E, Atwood, S M, Cummins, T J, Dewhurst, S
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Microbiology (ASM) 1995
Gaiak:	Research Article
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC227945/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7714190/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jcm.33.2.342-347.1995
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!